Projecten per jaar
Vingerafdruk
- 1 Soortgelijke profielen
Samenwerkingen en hoofdonderzoeksgebieden uit de afgelopen vijf jaar
Projecten
- 1 Actief
-
Development of a human cell-based test system to evaluate the catalytic activity of ammonia lyase enzymes for therapeutic use in aminoacidopathies
Nulmans, I., Salvi, N. & De Kock, J., 5 mrt. 2025, (Unpublished).Onderzoeksoutput: Poster
-
A robust high-throughput screening system to assess bacterial tyrosine ammonia lyase activity in the context of tyrosine inherited metabolic disorders
Nulmans, I., Laga, C. A., Salvi, N. S., Desmet, L., Lequeue, S., Neuckermans, J., Schwaneberg, U. & De Kock, J., 27 sep. 2024, In: Scientific reports. 14, 1, 1 blz., 22175.Onderzoeksoutput: Article › peer review
Open AccessBestand1 Citaat (Scopus) -
Development of a robust high-throughput screenings system for the evaluation of tyrosine ammonia lyases in the context of inborn errors of tyrosine metabolism
Nulmans, I., Laga, C. A., Salvi, N. S., Desmet, L., Lequeue, S., Neuckermans, J. & De Kock, J., 19 sep. 2023.Onderzoeksoutput: Poster
-
A robust bacterial high-throughput screening system to evaluate single nucleotide polymorphisms of human homogentisate 1,2-dioxygenase in the context of alkaptonuria
Lequeue, S., Neuckermans, J., Nulmans, I., Schwaneberg, U., Vanhaecke, T. & De Kock, J., 14 nov. 2022, In: Scientific Reports. 12, 1, blz. 1-15 15 blz., 19452.Onderzoeksoutput: Article › peer review
Open AccessBestand3 Citaten (Scopus)61 Downloads (Pure) -
Development of an adverse outcome pathway network for breast cancer: a comprehensive representation of the pathogenesis, complexity and diversity of the disease
Del'Haye, G., Nulmans, I., Bouteille, S. P., Sermon, K., Wellekens, B., Rombaut, M., Vanhaecke, T., Vander Heyden, Y. & De Kock, J., 4 aug. 2022, In: Archives of Toxicology. 96, 11, blz. 2881-2897 17 blz.Onderzoeksoutput: Article › peer review
Open AccessBestand7 Citaten (Scopus)83 Downloads (Pure)
Prijzen
-
PiKachU: Development of human phenylalanine ammonia lyase enzymes to treat phenylketonuria using directed protein evolution
Nulmans, Ine (Recipient), 8 okt. 2021
Prijs: Fellowship awarded competitively
Activiteiten
-
Faculteit van de Geneeskunde en Farmacie (Organisatie)
Ine Nulmans (Member)
jun. 2024 → …Activiteit: Work on academic committees and working groups
-
Vrije Universiteit Brussel (Organisatie)
Ine Nulmans (Member)
mrt. 2023 → …Activiteit: Work on academic committees and working groups
-
Society for The Study of Inborn Errors of Metabolism Annual Symposium 2023
Ine Nulmans (Participant)
27 aug. 2023 → 1 sep. 2023Activiteit: Participation in conference
-
A robust high-throughput screening assay for the evaluation of bacterial tyrosine ammonia lyase enzymes in the context of nitisinone-induced hypertyrosinemia in inborn errors of tyrosine metabolism
Ine Nulmans (Invited speaker)
12 dec. 2023Activiteit: Talk or presentation at a workshop/seminar
-
Development of a robust high-throughput screenings assay for the evaluation of bacterial tyrosine ammonia lyases in the context of tyrosinemia type 1 and alkaptonuria
Ine Nulmans (Invited speaker)
27 jul. 2023 → 28 jul. 2023Activiteit: Talk or presentation at a conference
Scriptie
-
The development of a high-throughput screening assay to evaluate the catalytic activity and substrate specificity of human histidine ammonia lyase variants
Auteur: Neuckermans, J., Nulmans, I. & De Kock, J., 2021Scriptie/Masterproef: Master's Thesis
-
The development of a high-througput screening assay to evaluate the catalytic activity and substrate specificity of human histidine ammonia lyase variants
Auteur: Nulmans, I. & De Kock, J., 2021Begeleider: De Kock, J. (Promotor)
Scriptie/Masterproef: Master's Thesis